AC Immune SA - ACIU

About Gravity Analytica
Recent News
- 03.11.2025 - Barclays 27th Annual Global Healthcare Conference
- 03.11.2025 - Barclays 27th Annual Global Healthcare Conference
- 03.10.2025 - Leerink Partners 2025 Global Healthcare Conference
- 03.10.2025 - Leerink Partners 2025 Global Healthcare Conference
- 03.04.2025 - AC Immune to Participate in Upcoming Investor Conferences
- 03.04.2025 - AC Immune to Participate in Upcoming Investor Conferences
- 12.10.2024 - AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome
- 12.10.2024 - AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome
- 12.10.2024 - AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome
- 11.20.2024 - Jefferies 2024 London Healthcare Conference
Recent Filings
- 12.18.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 12.13.2024 - SC 13G/A Statement of Beneficial Ownership by Certain Investors
- 12.10.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 12.10.2024 - EX-99.1 EX-99.1
- 11.14.2024 - SC 13G/A Statement of Beneficial Ownership by Certain Investors
- 11.14.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]